Article | Health, Technology & Innovation
A new Medicare pathway promises faster, more predictable coverage for breakthrough medical devices. When participation is voluntary, however, and manufacturers can take other routes, the real test is not who enters the fast lane, but what Medicare learns about those who don’t.